Highlights
NASDAQ: CLLS       Cellectis S.A. ADR
Last Price Today's Change   Day's Range   Trading Volume
16.50   0.00 (0.00%)  0.00 - 0.00  0

Overview

 
Avg Volume (4 weeks):142,255
4 Weeks Range:15.78 - 18.80
4 Weeks Price Volatility (%):
87.77%
52 Weeks Range:9.50 - 20.84
52 Weeks Price Volatility (%):
79.17%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Cellectis SA is a biotechnology company focused on developing immunotherapies for cancer. The company engages in gene editing in an attempt to lead the body’s immune system toward attacking cancer cells. Cellectis utilizes strategic corporate partnerships along with cooperation through various university clinical centers. The company’s gene-editing technologies allow for the creation of healthy cells derived from healthy donors rather than the patients themselves. The company reports two segments: Therapeutics and Plants. Its Therapeutics segment focuses on novel cancer therapies, while its Plants segment focuses on agricultural biotechnology.

  Be the first to like this.
 


 

8896 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 HIPS 17.070.00 
 HONE 11.030.00 
 ENZL 57.410.00 
 KOD 64.880.00 
 UPRO 72.870.00 
 COLD 35.090.00 
 UBIO 29.9460.00 
 ALYA 2.680.00 
 CIGI 82.100.00 
 AXNX 30.770.00 
Partners & Brokers